1,595 Shares in Cencora, Inc. $COR Acquired by PCM Encore LLC

PCM Encore LLC bought a new stake in Cencora, Inc. (NYSE:COR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,595 shares of the company’s stock, valued at approximately $451,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Accent Capital Management LLC boosted its position in shares of Cencora by 36.1% in the fourth quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock worth $38,000 after buying an additional 30 shares during the period. MCF Advisors LLC raised its holdings in shares of Cencora by 11.0% during the 4th quarter. MCF Advisors LLC now owns 303 shares of the company’s stock valued at $102,000 after buying an additional 30 shares during the period. CYBER HORNET ETFs LLC lifted its position in Cencora by 6.8% during the 4th quarter. CYBER HORNET ETFs LLC now owns 485 shares of the company’s stock worth $164,000 after acquiring an additional 31 shares in the last quarter. Steph & Co. lifted its position in Cencora by 23.5% during the 1st quarter. Steph & Co. now owns 168 shares of the company’s stock worth $53,000 after acquiring an additional 32 shares in the last quarter. Finally, Beacon Pointe Advisors LLC boosted its holdings in Cencora by 1.1% in the 4th quarter. Beacon Pointe Advisors LLC now owns 3,492 shares of the company’s stock worth $1,180,000 after acquiring an additional 37 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Activity

In related news, Director Lauren M. Tyler purchased 550 shares of Cencora stock in a transaction dated Monday, June 22nd. The shares were acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the transaction, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.38% of the company’s stock.

Cencora Price Performance

COR stock opened at $315.15 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.93 and a debt-to-equity ratio of 3.53. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The stock’s 50 day moving average is $301.86 and its two-hundred day moving average is $311.85. The company has a market capitalization of $60.14 billion, a PE ratio of 23.41, a P/E/G ratio of 1.82 and a beta of 0.57.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The company had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. During the same period in the prior year, the company posted $4.00 EPS. Cencora’s quarterly revenue was up 5.1% on a year-over-year basis. Analysts predict that Cencora, Inc. will post 17.87 earnings per share for the current fiscal year.

Cencora declared that its Board of Directors has approved a stock repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a $0.60 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s payout ratio is presently 17.83%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on COR shares. Barclays dropped their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 10th. Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 6th. Wall Street Zen raised shares of Cencora from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Royal Bank Of Canada assumed coverage on shares of Cencora in a report on Wednesday. They set a “sector perform” rating and a $330.00 price target for the company. Finally, Evercore reaffirmed an “outperform” rating and set a $350.00 price target on shares of Cencora in a research note on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $370.85.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.